Login
Please select your location and reference genome:

Latest News and Blogs

A fast and reliable method to reach a conclusive diagnosis of MYH9-related disorder

A fast and reliable method to reach a conclusive diagnosis of MYH9-related disorder

Congenica platform provides variant review and assessment to support conclusive diagnoses for patients with complex and commonly misdiagnosed bleeding disorders.

Congenica Appoints Dr. Heiner Dreismann as Non-Executive Director

Congenica Appoints Dr. Heiner Dreismann as Non-Executive Director

Congenica Ltd, has announced the appointment of Dr Heiner Dreismann as non-executive Director and Senior Independent Director on the board.

Congenica named MedTech Company of the Year 2019

Congenica named MedTech Company of the Year 2019

Congenica has been named MedTech Company of the Year 2019 at the Cambridge Independent Science and Technology Awards 2019 at a ceremony held in Cambridge.

ExomeCG to simplify molecular and cytogenomic data generation and interpretation

ExomeCG to simplify molecular and cytogenomic data generation and interpretation

Nonacus Ltd has announced the launch of ExomeCG, a new product designed by Congenica to simplify the generation and interpretation of molecular and cytogenomic data.

Prenatal exome sequencing in unexplained fetal oedema: a game changer

Prenatal exome sequencing in unexplained fetal oedema: a game changer

Prenatal exome sequencing in unexplained fetal oedema: a game changer

Congenica Integrates Powerful New Curated Data

Congenica Integrates Powerful New Curated Data

Congenica has announced the integration of powerful new reference data sources, DECIPHER and Mastermind® into its clinical decision support platform.

How to select a clinical decision support platform

How to select a clinical decision support platform

How is genomic clinical decision support being used to address the challenges in medicine? How it is helping clinicians realize the potential of genomics?

Highlights from the International Conference on Prenatal Diagnosis and Therapy

Highlights from the International Conference on Prenatal Diagnosis and Therapy

Highlights from the International Conference on Prenatal Diagnosis and Therapy

Poster: Towards Improved Next Generation Sequencing for Ultrasound Abnormalities (INGENIOUS) using cell-free DNA

Poster: Towards Improved Next Generation Sequencing for Ultrasound Abnormalities (INGENIOUS) using cell-free DNA

Invasive fetal sampling is currently the only way to comprehensively test genomic material for single gene disorders, for example using exome sequencing.

Poster: Diagnosis of fetal structural abnormalities using whole exome sequencing: a single centre study

Poster: Diagnosis of fetal structural abnormalities using whole exome sequencing: a single centre study

Fetal anomalies are identified in ~2-5% of pregnancies and are responsible for ~20% of perinatal deaths.

Neurodevelopmental disorders - discovering the underlying cause and how genomic data analysis ended a 21-year diagnostic odyssey

Neurodevelopmental disorders - discovering the underlying cause and how genomic data analysis ended a 21-year diagnostic odyssey

Thousands of babies are born each year with a neurodevelopmental disorder and the global estimate for individuals with intellectual disability is 10.37/1,000 (1) and 62/10,000 (2) for autism.

Congenica a finalist in multiple industry awards

Congenica a finalist in multiple industry awards

Congenica a finalist in multiple industry awards